The Effect of Lavender Essential Oil for Delirium in Elderly Intensive Care Unit Patients: Study Protocol
Launched by CHONGQING TRADITIONAL CHINESE MEDICINE HOSPITAL · Oct 20, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether lavender essential oil can help prevent delirium in elderly patients who are critically ill and in the intensive care unit (ICU). Delirium is a serious condition that can affect a person's thinking, memory, and awareness, and it is common among older patients in the ICU. The researchers believe that inhaling lavender oil may help reduce the chances of developing delirium, especially since it has been shown to improve sleep and relieve anxiety in other situations.
To participate in this study, patients need to be between 60 and 90 years old, expected to stay in the ICU for at least 72 hours, and admitted to the ICU within the last 48 hours. They must also be able to provide consent to participate. However, those who are in a coma, have certain psychiatric conditions, or have a history of severe brain issues are not eligible. If someone joins the study, they will be given the opportunity to inhale lavender oil while their health is monitored, helping to see if it can make a difference in preventing delirium during their hospital stay.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Critically ill patients aged between 60 and 90 years old
- • Had an expected total ICU length of stay (LOS) of 72 hours or more
- • Admitted to the ICU within 48 hours before screening
- • Signed the informed consent form.
- Exclusion Criteria:
- • Incapacitation preventing the assessment of delirium (i.e., coma, sedation, or active seizures)
- • History of psychiatric disorders, dementia, Parkinson's disease, use of antipsychotic drugs, or alcohol dependence
- • History of traumatic brain injury or brain infection
- • Diagnosis of delirium prior to intervention initiation
- • Allergies to medications used in the protocol or current participation in other drug studies
- • Inability to communicate in Chinese or English
- • Expected to be discharged or deceased within 72 hours of admission.
About Chongqing Traditional Chinese Medicine Hospital
Chongqing Traditional Chinese Medicine Hospital is a leading institution dedicated to the integration of traditional Chinese medicine (TCM) and modern healthcare practices. With a focus on advancing clinical research and enhancing patient care, the hospital is committed to exploring the efficacy and safety of TCM therapies through rigorous clinical trials. Its multidisciplinary team of experienced healthcare professionals and researchers collaborates to foster innovation and evidence-based practices, aiming to improve health outcomes and promote the understanding of traditional medicine in contemporary healthcare settings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chongqing, , China
Patients applied
Trial Officials
Dongsheng Ren
Study Director
Chongqing Traditional Chinese Medicine Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported